Fawzi Abukhalil, MD
Neurology · Coral Springs, FLNPI 1881983773
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.3% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 33.1% of the total. Reporting peaked in 2021 at $333 and has fallen 82.9% since, to $57 in 2022. That places this record below the midpoint for neurology clinicians in FL, where the typical reported total is $1,698.
Across 25 payments — averaging $17.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$141
- Tanabe Pharma America, Inc.$47
- Amgen$43
- Aprecia Pharmaceuticals, LLC$42
- Biogen$29
- AbbVie$27
- plus $97 from 5 others
What the payments were for
- Food & beverage$40394%
- Education$246%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $141 |
| Tanabe Pharma America, Inc. | 2 | $47 |
| Amgen | 2 | $43 |
| Aprecia Pharmaceuticals, LLC | 2 | $42 |
| Biogen | 2 | $29 |
| AbbVie | 2 | $27 |
| Eisai Inc. | 1 | $24 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| SK Life Science, Inc. | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
How this compares
$427 in reported general payments places this provider in the 30th percentile of 1,434 neurology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Coral Springs
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
- Matthew BakerNaples$1.4M
- Donald NegroskiSarasota$1.4M
- Mark CascioneTampa$1.2M
- Lance KimOcala$1M
- Tuan VuTampa$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.